Eva Strijbis

52PUBLICATIONS
198CO-AUTHORS
Molecular targetsPeripheral nervous systemComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Information modelling, management and ontologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jun 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

|Jun 17, 2026
Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple Sclerosis.

|Jun 08, 2026
The constrained brain in multiple sclerosis: Cognitive impairment is related to network-specific coupling of structural and functional connectivity.

|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions.

|May 08, 2026
Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts.

|Mar 29, 2026
Novel MRI metrics: Is targeting brain atrophy a practical treatment goal? No.

Eva M M Strijbis, Menno M Schoonheim

Pageof 9

Frequent Collaborators

20 joint publications

Menno M Schoonheim

16 joint publications

Frederik Barkhof

14 joint publications

Zoé LE Van Kempen

13 joint publications

Marcus Werner Koch